Page last updated: 2024-10-31

mianserin and Cancer of Esophagus

mianserin has been researched along with Cancer of Esophagus in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hannon, B1
Fitzgerald, P1
Murphy, M1
Masuzawa, M1
Taguchi, H1
Sugimoto, T1
Kojima, H1
Matsumoto, S1
Kojima, K1
Shingu, K1

Other Studies

2 other studies available for mianserin and Cancer of Esophagus

ArticleYear
Treatment of depression as part of end-of-life care.
    BMJ case reports, 2008, Volume: 2008

    Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamou

2008
[Case of successful management with mirtazapine for prolonged pain after esophagectomy].
    Masui. The Japanese journal of anesthesiology, 2012, Volume: 61, Issue:9

    Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Esophageal Neoplasms; Esophagectomy;

2012